United States
Germany
Japan
United Kingdom
China
Fibrinogen goat polyclonal antibody, FITC
| Applications | ELISA, ID, IF, IP |
| Reactivities | Canine |
Products
Goat Polyclonal Anti-Rab4 Antibody
| Applications | WB |
| Reactivities | Canine, Human, Monkey, Mouse, Rat |
Goat Polyclonal Anti-REP1 Antibody
| Applications | WB |
| Reactivities | Canine, Human, Monkey, Mouse, Rat |
CNY 5,973.00
5周
Vimentin (VIM) (incl. pos. control) mouse monoclonal antibody, clone 11H6, Purified
| Applications | WB |
| Reactivities | Canine, Human, Mouse |
Goat Polyclonal Anti-Rab9b Antibody
| Applications | WB |
| Reactivities | Canine, Human, Monkey, Mouse, Rat |
Goat Polyclonal Anti-Rab2b Antibody
| Applications | WB |
| Reactivities | Canine, Human, Monkey, Mouse, Rat |
ACRV1 mouse monoclonal antibody, clone Ds-2, Purified
| Applications | IF, WB |
| Reactivities | Canine |
Cytochrome C (CYCS) sheep polyclonal antibody, Purified
| Applications | IHC, IP, WB |
| Reactivities | Canine, Human, Rabbit, Rat |
BCL2 sheep polyclonal antibody, Purified
| Applications | IF, IP, WB |
| Reactivities | Canine, Human, Rat |
Dnm1 pSer774 sheep polyclonal antibody, Purified
| Applications | IF, IHC, WB |
| Reactivities | Bovine, Canine, Chicken, Human, Monkey, Mouse, Rat |
Canine IgG (Fc specific) goat polyclonal antibody, Azide Free
| Applications | Can be used as unlabelled primary or secondary reagent for indirect detection of IgG at the cellular and subcellular level by staining of appropriately treated cell and tissue substrates; to prepare conjugates of the user’s own choice; to prepare an insoluble immunoaffinity adsorbent or a solid phase antibody reagent by coupling to an artificial carrier and as catching antibody in non-isotopic methodology and solid phase immunochemistry. When applied in any cytochemical or histochemical staining procedure or solid phase coupling technique, the optimum concentration of the IgG preparation should be established by titration before being used. Typical working dilutions: In histochemistry are usually between 1/50 and 1/250. In ELISA and comparable non-precipitating antibody-binding assays between 1/1000 and 1/5000. |
| Reactivities | Canine |
| Conjugation | Unconjugated |
Canine IgA (Fc specific) goat polyclonal antibody, Azide Free
| Applications | Can be used as unlabelled primary or secondary reagent for indirect detection techniques, to prepare conjugates with markers of the user’s own choice, to prepare an insoluble immunoaffinity adsorbent or a solid phase antibody reagent by coupling to an artificial carrier and as catching or detection antibody in non-isotopic methodology and solid phase immunochemistry. When applied in any cytochemical or histochemical procedure or solids phase coupling technique, the optimum concentration of the IgG preparation should always be established by titration. Typical working dilutions: In histochemistry are usually between 1/50 and 1/250. In ELISA and comparable non-precipitating antibody-binding assays between 1/500 and 1/2000. |
| Reactivities | Canine |
| Conjugation | Unconjugated |
Canine IgM (Fc specific) goat polyclonal antibody, Azide Free
| Applications | As unlabelled primary or secondary reagent for indirect detection techniques, to prepare conjugates with markers of the user’s own choice, to prepare an insoluble immunoaffinity adsorbent or a solid phase antibody reagent by coupling to an artificial carrier and as catching or detection antibody in non-isotopic methodology and solid phase immunochemistry. When applied in any cytochemical or histochemical procedure or solids phase coupling technique, the optimum concentration of the IgG preparation should always be established by titration. Typical working dilutions: In histochemistry are usually between 1/50 and 1/250. In ELISA and comparable non-precipitating antibody-binding assays between 1/500 and 1/3000. |
| Reactivities | Canine |
| Conjugation | Unconjugated |
Canine IgM (Fc specific) goat polyclonal antibody, Biotin
| Applications | Can be used in immunocytochemical and immunohistochemical use for the detection of IgM at the cellular and subcellular level by staining of appropriately treated cell and tissue substrates; to demonstrate circulating IgM antibodies in serodiagnostic microbiology and autoimmune diseases; to identify a specific antigen using an reference antibody of goat origin known to be of the IgM isotype in the middle layer of the indirect test procedure; in non-isotopic assay methodology (e.g. ELISA) to measure IgM in dog serum or other body fluids. As a second step an avidin or streptavidin conjugate of the user’s choice has to be used. This immunoconjugate is not pre-diluted. The optimum working dilution of each conjugate should be established by titration before being used. Excess labelled antibody must be avoided because it may cause high unspecific background staining and interfere with the specific signal. Working dilutions: For histochemical and cytochemical use are usually between 1/100 and 1/250. In ELISA and comparable non-precipitating antibody-binding assays between 1/1000 and 1/4000. |
| Reactivities | Canine |
| Conjugation | Biotin |
Canine IgG (Fc specific) goat polyclonal antibody, Biotin
| Applications | Can be used in immunocytochemical and immunohistochemical use for the detection of IgG at the cellular and subcellular level by staining of appropriately treated cell and tissue substrates; to demonstrate circulating IgG antibodies in serodiagnostic microbiology and autoimmune diseases; to identify a specific antigen using an reference antibody of goat origin known to be of the IgG isotype in the middle layer of the indirect test procedure; in non-isotopic assay methodology (e.g. ELISA) to measure IgG in dog serum or other body fluids. As a second step an avidin or streptavidin conjugate of the user’s choice has to be used. This immunoconjugate is not pre-diluted. The optimum working dilution of each conjugate should be established by titration before being used. Excess labelled antibody must be avoided because it may cause high unspecific background staining and interfere with the specific signal. Working dilutions: For histochemical and cytochemical use are usually between 1/100 and 1/250. In ELISA and comparable non-precipitating antibody-binding assays between 1/500 and 1/5000. |
| Reactivities | Canine |
| Conjugation | Biotin |
活动过滤器
优化搜索结果
Target Symbol
- RAB27A (5)
- ATAXIN 3 (4)
- CALNEXIN (4)
- CHM (4)
- ERP57 (4)
- GJA1 (4)
- ALPHA TUBULIN (3)
- GAPDH (3)
- RAB11A (3)
- RAB5 (3)
- SAE1 (3)
- CATHEPSIN D (2)
- CD19 (2)
- CD45 (2)
- CD63 (2)
- CDC27 (2)
- E CADHERIN (2)
- GAP43 (2)
- GFAP (2)
- HIF-1 ALPHA (2)
- P53 (2)
- RAB14 (2)
- RAB1B (2)
- RAB9A (2)
- RPS6KA1 (2)
- TIMP3 (2)
- ACRV1 (1)
- AIRE (1)
- ALB (1)
- ALBUMIN (1)
- ANKRD32 (1)
- APG12 (1)
- APOLIPOPROTEIN H (1)
- ARHGEF11 (1)
- AXIN1 (1)
- BAX (1)
- BCL2 (1)
- BETA ACTIN (1)
- BETA CATENIN (1)
- BMI1 (1)
- C-PEPTIDE (1)
- C3 (1)
- CALR (1)
- CATALASE (1)
- CAVEOLIN 1 (1)
- CAVEOLIN 2 (1)
- CD2 (1)
- CD31 (1)
- CD3E (1)
- CD4 (1)
- CREBRF (1)
- CYCS (1)
- DNM1 (1)
- EDG8 (1)
- EEA1 (1)
- EGFR (1)
- EPHA2 (1)
- FBXO9 (1)
- FKBP51 (1)
- FTCD (1)
- GAMMA SYNUCLEIN (1)
- GRIA1 (1)
- GSK3B (1)
- HC (1)
- HER2 (1)
- HSP70-1A (1)
- IL10 (1)
- INSULIN (1)
- INSULIN RECEPTOR (1)
- KCNN4 (1)
- LAMIN A (1)
- MACROPHAGE SCAVENGER RECEPTOR I (1)
- MAP2K5 (1)
- MAPK14 (1)
- MARK2 (1)
- MTOR (1)
- MYH (1)
- N CADHERIN (1)
- NOS1 (1)
- NRAS (1)
- NUCLEOBINDIN 2 (1)
- NUCLEOLIN (1)
- PC (1)
- PDE11A (1)
- PIN1 (1)
- PPARG (1)
- PPP1R1B (1)
- RAB10 (1)
- RAB11 (1)
- RAB15 (1)
- RAB1A (1)
- RAB2 (1)
- RAB20 (1)
- RAB25 (1)
- RAB27B (1)
- RAB28 (1)
- RAB2B (1)
- RAB31 (1)
- RAB32 (1)
- RAB35 (1)
Applications
Antibody Hosts
Conjugates
Clonalities
Assay Types
Families
- Druggable Genome (102)
- Transmembrane (34)
- ES Cell Differentiation/IPS (18)
- Transcription Factors (15)
- Secreted Protein (8)
- Protein Kinase (6)
- Stem cell - Pluripotency (4)
- Ion Channels: Other (3)
- Adult stem cells (2)
- Phosphatase (2)
- Protease (2)
- Cancer stem cells (1)
- GPCR (1)
- Induced pluripotent stem cells (1)
- Ion Channels: Potassium (1)
- Stem cell relevant signaling - JAK/STAT signaling pathway (1)
Pathways
- Endocytosis (15)
- Pathways in cancer (11)
- Antigen processing and presentation (10)
- Focal adhesion (9)
- Pathogenic Escherichia coli infection (9)
- Adherens junction (8)
- Amyotrophic lateral sclerosis (ALS) (8)
- Cell adhesion molecules (CAMs) (8)
- Gap junction (8)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (7)
- Bladder cancer (7)
- Endometrial cancer (7)
- MAPK signaling pathway (6)
- Prostate cancer (6)
- Colorectal cancer (5)
- Cytokine-cytokine receptor interaction (5)
- Hematopoietic cell lineage (5)
- Melanoma (5)
- Metabolic pathways (5)
- Pancreatic cancer (5)
- Primary immunodeficiency (5)
- T cell receptor signaling pathway (5)
- Thyroid cancer (5)
- mTOR signaling pathway (5)
- Alzheimer's disease (4)
- Apoptosis (4)
- Leukocyte transendothelial migration (4)
- Lysosome (4)
- Non-small cell lung cancer (4)
- Regulation of actin cytoskeleton (4)
- Wnt signaling pathway (4)
- Basal cell carcinoma (3)
- Dilated cardiomyopathy (3)
- Glioma (3)
- Glycolysis / Gluconeogenesis (3)
- Huntington's disease (3)
- Hypertrophic cardiomyopathy (HCM) (3)
- Insulin signaling pathway (3)
- Neurotrophin signaling pathway (3)
- Renal cell carcinoma (3)
- Tight junction (3)
- Type II diabetes mellitus (3)
- p53 signaling pathway (3)
- Allograft rejection (2)
- Asthma (2)
- B cell receptor signaling pathway (2)
- Calcium signaling pathway (2)
- Cell cycle (2)
- Chronic myeloid leukemia (2)
- Epithelial cell signaling in Helicobacter pylori infection (2)
- ErbB signaling pathway (2)
- Fc gamma R-mediated phagocytosis (2)
- Prion diseases (2)
- RIG-I-like receptor signaling pathway (2)
- Regulation of autophagy (2)
- Ribosome (2)
- Small cell lung cancer (2)
- Systemic lupus erythematosus (2)
- TGF-beta signaling pathway (2)
- Toll-like receptor signaling pathway (2)
- Type I diabetes mellitus (2)
- VEGF signaling pathway (2)
- Vibrio cholerae infection (2)
- Viral myocarditis (2)
- Adipocytokine signaling pathway (1)
- Autoimmune thyroid disease (1)
- Axon guidance (1)
- Base excision repair (1)
- Chemokine signaling pathway (1)
- Dorso-ventral axis formation (1)
- Fc epsilon RI signaling pathway (1)
- GnRH signaling pathway (1)
- Graft-versus-host disease (1)
- Histidine metabolism (1)
- Jak-STAT signaling pathway (1)
- Maturity onset diabetes of the young (1)
- Melanogenesis (1)
- Methane metabolism (1)
- NOD-like receptor signaling pathway (1)
- Natural killer cell mediated cytotoxicity (1)
- Neuroactive ligand-receptor interaction (1)
- One carbon pool by folate (1)
- Oocyte meiosis (1)
- Progesterone-mediated oocyte maturation (1)
- SNARE interactions in vesicular transport (1)
- Spliceosome (1)
- Tryptophan metabolism (1)
- Ubiquitin mediated proteolysis (1)
- Vascular smooth muscle contraction (1)
